Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-293

Eur Urol. 2022 May;81(5):e123. doi: 10.1016/j.eururo.2022.01.048. Epub 2022 Feb 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androgen Antagonists* / therapeutic use
  • COVID-19 Drug Treatment*
  • Clinical Trials, Phase II as Topic
  • Hormone Replacement Therapy
  • Humans

Substances

  • Androgen Antagonists